|
Video: What is a Stock Split?
|
|
Spherix is a biotechnology company seeking to develop small-molecule anti-cancer therapeutics. Co. owns the rights to patented technology from universities and researchers and it is in the process of developing therapeutic drugs through partnerships with educational institutions. Co.'s pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Co.'s AML and ALL compounds are targeted therapeutics designed to overcome various resistance mechanisms observed with the existing standard of care. DHA-dFdC, Co.'s pancreatic drug, is a compound poised to become the chemotherapy treatment for pancreatic cancer. According to our AIKI split history records, AIKI has had 1 split. | |
|
AIKI (AIKI) has 1 split in our AIKI split history database. The split for AIKI took place on June 07, 2022. This was a 1 for 17 reverse split, meaning for each 17 shares of AIKI owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 58.8235294117647 share position following the split.
When a company such as AIKI conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the AIKI split history from start to finish, an original position size of 1000 shares would have turned into 58.8235294117647 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AIKI shares, starting with a $10,000 purchase of AIKI, presented on a split-history-adjusted basis factoring in the complete AIKI split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
12/21/2022 |
|
Start price/share: |
$51.17 |
|
End price/share: |
$3.56 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-93.04% |
|
Average Annual Total Return: |
-26.31% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$696.05 |
|
Years: |
8.73 |
|
|
|
Date |
Ratio |
06/07/2022 | 1 for 17 |
|
|